Edgewise Therapeutics, Inc.
US ˙ NasdaqGS ˙ US28036F1057

SecurityEWTX / Edgewise Therapeutics, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership1,219,717 shares
Latest Disclosed Value $ 38,412,551
Dimensional Fund Advisors Lp reports 0.50% increase in ownership of EWTX / Edgewise Therapeutics, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 1,219,717 shares of Edgewise Therapeutics, Inc. (US:EWTX) valued at $38,421,086 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,213,657 shares of Edgewise Therapeutics, Inc.. This represents a change in shares of 0.50% during the quarter. The current value of the position is $43,409,728 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F EDGEWISE THERAPEUTICS COM 28036F105 1,219,717 6,060 0.50 38,413 27.56 0.0017
2026-02-12 2025-12-31 13F EDGEWISE THERAPEUTICS COM 28036F105 1,213,657 30,521 2.58 30,115 56.95 0.0063
2025-11-12 2025-09-30 13F EDGEWISE THERAPEUTICS COM 28036F105 1,183,136 134,200 12.79 19,187 39.53 0.0041
2025-08-12 2025-06-30 13F EDGEWISE THERAPEUTICS COM 28036F105 1,048,936 381,437 57.14 13,752 -6.40 0.0032
2025-05-13 2025-03-31 13F EDGEWISE THERAPEUTICS COM 28036F105 667,499 -62,424 -8.55 14,692 -24.62 0.0037
2025-02-13 2024-12-31 13F EDGEWISE THERAPEUTICS COM 28036F105 729,923 3,052 0.42 19,491 0.48 0.0047
2024-11-07 2024-09-30 13F EDGEWISE THERAPEUTICS COM 28036F105 726,871 259,364 55.48 19,397 130.44 0.0047
2024-08-09 2024-06-30 13F EDGEWISE THERAPEUTICS COM 28036F105 467,507 168,219 56.21 8,417 54.19 0.0022
2024-05-10 2024-03-31 13F EDGEWISE THERAPEUTICS COM 28036F105 299,288 37,050 14.13 5,459 90.14 0.0015
2024-02-07 2023-12-31 13F EDGEWISE THERAPEUTICS COM 28036F105 262,238 87,317 49.92 2,871 186.53 0.0008
2023-11-09 2023-09-30 13F EDGEWISE THERAPEUTICS COM 28036F105 174,921 101,863 139.43 1,003 77.35 0.0003
2023-08-09 2023-06-30 13F EDGEWISE THERAPEUTICS COM 28036F105 73,058 45,775 167.78 566 212.15 0.0002
2023-05-12 2023-03-31 13F EDGEWISE THERAPEUTICS COM 28036F105 27,283 1,091 4.17 182 0.0001
2023-02-09 2022-12-31 13F EDGEWISE THERAPEUTICS COM 28036F105 26,192 12 0.05 0 -100.00 0.0001
2022-11-10 2022-09-30 13F EDGEWISE THERAPEUTICS COM 28036F105 26,180 26,180 258 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.